Related references
Note: Only part of the references are listed.Targeting EZH2 as cancer therapy Comment
Shunsuke Hanaki et al.
JOURNAL OF BIOCHEMISTRY (2021)
Dual targeting of EZH2 and androgen receptor as a novel therapy for castration-resistant prostate cancer
Eswar Shankar et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2020)
Leucine-Rich Repeat Extensin Proteins and Their Role in Cell Wall Sensing
Aline Herger et al.
CURRENT BIOLOGY (2019)
Control of neural development and function by glial neuroligins
Kristina Sakers et al.
CURRENT OPINION IN NEUROBIOLOGY (2019)
Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing
Rahul Nahar et al.
NATURE COMMUNICATIONS (2018)
Molecular Diversity and Specializations among the Cells of the Adult Mouse Brain
Arpiar Saunders et al.
CELL (2018)
Gene expression analyses identify a relationship between stanniocalcin 2 and he malignant behavior of colorectal cancer
Jian Wang et al.
ONCOTARGETS AND THERAPY (2018)
EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?
Ke-Sin Yan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
Collin M. Blakely et al.
NATURE GENETICS (2017)
Targeting EZH2 in cancer therapy
Makoto Yamagishi et al.
CURRENT OPINION IN ONCOLOGY (2017)
Specification of synaptic connectivity by cell surface interactions
Joris de Wit et al.
NATURE REVIEWS NEUROSCIENCE (2016)
Emerging roles for Polycomb proteins in cancer
Diego Pasini et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2016)
Single-cell RNAseq reveals cell adhesion molecule profiles in electrophysiologically defined neurons
Csaba Foldy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Targeting EZH2 for Cancer Therapy: Progress and Perspective
Chi Han Li et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2015)
Identification of Neurexophilin 3 as a Novel Supportive Factor for Survival of Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitors
Kaneyasu Nishimura et al.
STEM CELLS TRANSLATIONAL MEDICINE (2015)
p16INK4A and p14ARF Gene Promoter Hypermethylation as Prognostic Biomarker in Oral and Oropharyngeal Squamous Cell Carcinoma: A Review
A. Al-Kaabi et al.
DISEASE MARKERS (2014)
Modulation of synaptic function through the α-neurexin-specific ligand neurexophilin-1
Gesche Born et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells
Eunhee Kim et al.
CANCER CELL (2013)
A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia
Camille Simon et al.
GENES & DEVELOPMENT (2012)
Histone methylation: a dynamic mark in health, disease and inheritance
Eric L. Greer et al.
NATURE REVIEWS GENETICS (2012)
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
Kexin Xu et al.
SCIENCE (2012)
p16INK4a/CDKN2 expression and its relationship with oral squamous cell carcinoma is our current knowledge enough?
Mario Perez-Sayans et al.
CANCER LETTERS (2011)
The Polycomb complex PRC2 and its mark in life
Raphael Margueron et al.
NATURE (2011)
p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors
C. Romagosa et al.
ONCOGENE (2011)
The susceptibility CDKN2 locus may have a role on prognosis of melanoma patients
M. Casula et al.
ANNALS OF ONCOLOGY (2010)
Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma
R. Sailasree et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Neuroligins and neurexins link synaptic function to cognitive disease
Thomas C. Sudhof
NATURE (2008)
Characterizing the cancer genome in lung adenocarcinoma
Barbara A. Weir et al.
NATURE (2007)
Share Paper
